-
Loading metrics
Open Access
Peer-reviewed
Research Article
Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia
-
Evgeniy Evdoshenko ,
Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – original draft
* E-mail: e.evdoshenko@centrems.com
Affiliation SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia
⨯ -
Alexandra Stepanova,
Roles Data curation, Formal analysis, Project administration, Writing – original draft
Affiliation SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia
⨯ -
Maria Shumilina,
Roles Writing – review & editing
Affiliation SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia
⨯ -
Maria Davydovskaya,
Roles Writing – review & editing
Affiliations State Budgetary Institution of Moscow City “Clinical Trials and Healthcare Technology Assessment Scientific-Research Centre of Moscow Department of Healthcare”, Moscow, Russian Federation, Pirogov Russian National Research Medical University, Moscow, Russia
⨯ -
Natalia Khachanova,
Roles Writing – review & editing
Affiliation Pirogov Russian National Research Medical University, Moscow, Russia
⨯ -
Nikolay Neofidov,
Roles Methodology
Affiliation SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia
⨯ -
Ivan Kalinin,
Roles Methodology
Affiliation SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia
⨯ - Ekaterina Popova,
- Ekaterina Dubchenko,
- Natalia Pozhidaeva,
- Andrey Volkov,
-
Stella Sivertseva,
Roles Investigation, Resources
Affiliation “Medical Sanitary Unit «Neftyanik», Tyumen Multiple Sclerosis Center, Tyumen, Russia
⨯ -
Anna Prilenskaya,
Roles Investigation, Resources
Affiliation “Medical Sanitary Unit «Neftyanik», Tyumen Multiple Sclerosis Center, Tyumen, Russia
⨯ -
Nadezhda Malkova,
Roles Investigation, Resources
Affiliations State Novosibirsk Regional Clinical Hospital, Center of MS and other AID of Nervous System, Novosibirsk, Russia, State Novosibirsk Medical University, Novosibirsk, Russia
⨯ -
Denis Korobko,
Roles Investigation, Resources
Affiliation State Novosibirsk Regional Clinical Hospital, Center of MS and other AID of Nervous System, Novosibirsk, Russia
⨯ -
Ilona Vergunova,
Roles Investigation, Resources
Affiliation State Novosibirsk Regional Clinical Hospital, Center of MS and other AID of Nervous System, Novosibirsk, Russia
⨯ - Sergey Shchur,
- [ ... ],
-
Gleb Makshakov
Roles Conceptualization, Data curation, Methodology, Project administration, Supervision, Visualization, Writing – original draft
Affiliation SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia
⨯ - [ view all ]
- [ view less ]
Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia
- Evgeniy Evdoshenko,
- Alexandra Stepanova,
- Maria Shumilina,
- Maria Davydovskaya,
- Natalia Khachanova,
- Nikolay Neofidov,
- Ivan Kalinin,
- Ekaterina Popova,
- Ekaterina Dubchenko,
- Natalia Pozhidaeva
- Published: May 28, 2019
- https://doi.org/10.1371/journal.pone.0217303